Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Experimental potency

These successes were by no means Isolated. Throughout the development of the series, intuition continued to play an important role In the selection of synthetic targets, and therefore It Is possible to make a rough overall comparison of the performances of the QSAR equations with the performance of Intuition. Of course, these two "rationale for synthesis would not necessarily conflict and almost half of the series seemed reasonable synthetic targets from either point of view. However, there were compounds which, because of either synthetic difficulty or simple obscurity, would not have been prepared without a specific QSAR-based recommendation, and there were other compounds which were synthesized despite unfavorable QSAR auguries. Finally, the compounds In Table lA of course predated any possible QSAR rationale. These considerations allow the 98 pyranenamines to be divided Into four classes, based on "rationale for synthesis" and the mean experimental potencies within each class to be computed ... [Pg.175]

In fact, a measure of the degree of confidence can be gained from the t calculation. Shown in Appendix A are columns for greater degrees of confidence. The value for df = 4 for a 98% confidence level is 3.747 and it can be seen that the experimentally calculated value is also greater than this value. Therefore, the level of confidence that these samples came from different populations is raised to 98%. However, the level of confidence in believing that these two samples came from separate populations does not extend to 99% (t = 4.604). Therefore, at the 98% confidence level this analysis indicates that the potency of human calcitonin is effectively increased by enrichment of G -protein in the cell. [Pg.228]

Numerous experimental therapeutics have shown potency in vitro however, when they are tested in vivo, they often lack significant efficacy. This is often attributed to unfavorable pharmacokinetic properties and systemic toxicity, which limit the maximum tolerated dose. These limitations can be overcome by use of drug carriers. Two general types of carrier systems have been designed drug conjugation to macromolecular carriers, such as polymers and proteins and drug encapsulation in nanocarriers, such as liposomes, polymersomes and micelles. [Pg.84]

Traditionally, in pursuit of their structure-activity relationships, medicinal chemists had focused almost exclusively on finding compounds with greater and greater potency. However, these SARs often ended up with compounds that were unsuitable for development as pharmaceutical products. These compounds would be too insoluble in water, or were not orally bioavailable, or were eliminated too quickly or too slowly from mammalian bodies. Pharmacologists and pharmaceutical development scientists for years had tried to preach the need for medicinal chemists to also think about other factors that determined whether a compound could be a medicine. Table 1.1 lists a number of factors that determine whether a potent compound has what it takes to become a drug. Experimentally, it was difficult to quantitate these other factors. Often, the necessary manpower resources would not be allocated to a compound until it had already been selected for project team status. [Pg.35]

Fig. 3 The SAR by NMR approach. Example of a small bidentate molecule designed using this approach. The example shown is for the design of a potent inhibitors of the matrix metalloproteinase MMP3. (a) Docked structures of the identified fragment leads are shown with cyan carbons, whereas the linked compound is shown with green carbon atoms. All structures were experimentally determined by NMR. (b) Chemical structures (and in vitro potencies) of the fragment leads and subsequent high-affinity linked compounds. Adapted from [7]... Fig. 3 The SAR by NMR approach. Example of a small bidentate molecule designed using this approach. The example shown is for the design of a potent inhibitors of the matrix metalloproteinase MMP3. (a) Docked structures of the identified fragment leads are shown with cyan carbons, whereas the linked compound is shown with green carbon atoms. All structures were experimentally determined by NMR. (b) Chemical structures (and in vitro potencies) of the fragment leads and subsequent high-affinity linked compounds. Adapted from [7]...
Experimental data (potency, selectivity, ADME, safety, physchem properties)... [Pg.146]

Page [2] contains the full original title page. Introduction by Walter Leslie Wilmshurst. "Alchemy is philosophy it is the philosophy, the seeking out of the Sophia in the mind." Theory of Transmutation The Golden Treatise The True Subject The Mysteries Experimental Method Manifestation of the Matter Mental Requisites and Impediments The Gross Work The Six Keys Rewards and Potencies... [Pg.39]


See other pages where Experimental potency is mentioned: [Pg.32]    [Pg.73]    [Pg.275]    [Pg.175]    [Pg.436]    [Pg.32]    [Pg.73]    [Pg.275]    [Pg.175]    [Pg.436]    [Pg.683]    [Pg.241]    [Pg.521]    [Pg.525]    [Pg.311]    [Pg.122]    [Pg.35]    [Pg.44]    [Pg.48]    [Pg.107]    [Pg.158]    [Pg.453]    [Pg.573]    [Pg.13]    [Pg.161]    [Pg.157]    [Pg.335]    [Pg.212]    [Pg.153]    [Pg.366]    [Pg.86]    [Pg.420]    [Pg.290]    [Pg.339]    [Pg.339]    [Pg.107]    [Pg.141]    [Pg.143]    [Pg.143]    [Pg.144]    [Pg.144]    [Pg.146]    [Pg.151]    [Pg.153]    [Pg.153]    [Pg.636]    [Pg.704]    [Pg.75]   
See also in sourсe #XX -- [ Pg.146 ]




SEARCH



Potency

© 2024 chempedia.info